... are the estimated savings that biosimilar versions of Neupogen ($5.7 billion) and Remicade ($17 billion) will yield during the first decade they are on the market, according to an analysis by Express Scripts Holding Co.
At Medicare is Simple, we look to educate and enable you to choose among Medicare plans to help find the policy that may best fit your needs. Get free quotes using our advanced quoting technology. HealthCare Reform is also a hot topic of interest to people of all ages, and we look to keep you updated on the issues relevant to learning more. Medicare Is Simple 800-442-4915
No comments:
Post a Comment